<description>&lt;div&gt;
&lt;a href="https://www.youtube.com/live/AZTt87Aicfg"&gt;Watch on Youtube&lt;/a&gt;&lt;br&gt;
&lt;br&gt;
In this fascinating interview, CEO Martin Gouldstone of Oncimmune #ONC takes Vox through:&lt;br&gt;
&lt;br&gt;
00:00. What the company does, its key USPs and how the proprietary IMMUNOinsights autoantibody profiling service helps Biopharma companies develop &amp;amp; monitor new drugs &amp;amp; precision medicines.&lt;br&gt;
08:30 Current demand picture, breakeven revenue &amp;amp; Aug FY25 visibility.&lt;br&gt;
&lt;br&gt;

&lt;/div&gt;
</description>

The Vox Markets Podcast

Vox Markets Podcast

1983: Q&A with Oncimmune CEO, Martin Gouldstone

NOV 11, 202419 MIN
The Vox Markets Podcast

1983: Q&A with Oncimmune CEO, Martin Gouldstone

NOV 11, 202419 MIN

Description

<div> <a href="https://www.youtube.com/live/AZTt87Aicfg">Watch on Youtube</a><br> <br> In this fascinating interview, CEO Martin Gouldstone of Oncimmune #ONC takes Vox through:<br> <br> 00:00. What the company does, its key USPs and how the proprietary IMMUNOinsights autoantibody profiling service helps Biopharma companies develop &amp; monitor new drugs &amp; precision medicines.<br> 08:30 Current demand picture, breakeven revenue &amp; Aug FY25 visibility.<br> <br> </div>